AUG 18, 2026 · OBSERVATIONAL STUDY
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
ClinicalTrials.gov
This is a registry study registration with no results reported; it describes planned observational data collection on TNBC and hereditary mutation carriers without outcome data to assess.
Reported
Planned enrollment3000
Primary outcome measure 1Prevalence of germline mutations (such as B…
Primary outcome measure 2Predictors of response to neo/adjuvant chem…